1. Home
  2. ASTC vs FEMY Comparison

ASTC vs FEMY Comparison

Compare ASTC & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$8.31

Market Cap

14.5M

Sector

Industrials

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$2.33

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTC
FEMY
Founded
1984
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
12.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ASTC
FEMY
Price
$8.31
$2.33
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
283.0K
131.4K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
2600.00
44.71
EPS
0.25
N/A
Revenue
$1,000,000.00
$2,293,313.00
Revenue This Year
N/A
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
$35.60
N/A
Revenue Growth
N/A
40.77
52 Week Low
$1.92
$0.29
52 Week High
$68.85
$6.29

Technical Indicators

Market Signals
Indicator
ASTC
FEMY
Relative Strength Index (RSI) 47.39 36.22
Support Level $2.69 $0.44
Resistance Level $8.70 $3.21
Average True Range (ATR) 1.35 0.30
MACD 0.41 -0.09
Stochastic Oscillator 36.36 13.73

Price Performance

Historical Comparison
ASTC
FEMY

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: